Monotherapy with metformin or glimepiride and changes in serum sialic acid in type 2 diabetes mellitus

British Journal of Diabetes and Vascular Disease

Volumn 11, Issue 3, 2011, Pages 137-140

  Rahman, Inayat Ur ^a   Malik, Salman Akbar ^a   Bashir, Mohammad ^b   Khan, Rooh Ullah ^c   Idrees, Muhammad ^d  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b KIMS   (Pakistan)

^c Bannu Medical College   (Pakistan)

^d KHYBER TEACHING HOSPITAL   (Pakistan)

Author keywords

glimepiride; metformin; sialic acid; type 2 diabetes

Indexed keywords

CHOLESTEROL; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SIALIC ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SERUM SIALIC ACID; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80052571323     PISSN: 14746514     EISSN: 17534305     Source Type: Journal    
DOI: 10.1177/1474651411412863     Document Type: Article

References (23)

1. Schauer R. Sialic acids and their role as biological markers. Trends Biochem Sci 1985 ; 10: 357-60. (Pubitemid 16220327)
2. Ng S., Dain JA The natural occurrence of sialic acids. In: Rosenberg A, Schengrund S (eds). Biological role of sialic acid. New York: Plenum, 1976 ; 59-102.
3. Chen JW, Gall MA, Yokohama H. et al. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care 1996 ; 19: 130-4.
4. Pickup JC, Mattock MB, Crook MA et al. Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 1995 ; 18: 1100-03.
5. Vijay V., Snehalatha C., Ramachandran A., Jayaraman M. Serum sialic acid in South Indian type 2 diabetic patients with microvascular complications (Letter). Diabetic Med 1998 ; 15: 176.
6. Crook MA, Earle K., Morocutti A. et al. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 1994 ; 17: 305-09.
7. Abdella N., Akanji AO, Mojiminiyi OA et al. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti type 2 diabetic patients. Diab Res Clin Pract 2000 ; 50: 65-72. (Pubitemid 30629021)
8. Islam N., Kazmi F., Chusney GD et al. Serum sialic acid and cardiovascular disease in Malay, Indian and Chinese subjects with NIDDM in Malaysia. Diabetes Res 1997 ; 31: 77-85.
9. Lindberg G., Eklund G.A., Gullberg BO, Rastam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991 ; 302: 143-6.
10. Lindberg G., Rastam L., Gullber BO, Eklund GA Serum sialic acid concentration predicts coronary heart disease and stroke mortality: multi-variate analysis including 54385 men and women during 30.5 years follow-up. Int J Epidemiol 1992 ; 21: 253-7.
11. Masuda H., Wakabayashi R., Wakabayashi I. Serum sialic acid and ankle versus brachial arterial pressure ratio in NIDDM. Scand J Clin Lab Invest 1998 ; 58: 433-9. (Pubitemid 28489473)
12. World Health Organization. Diet, nutrition and the prevention of chronic diseases. Report of a WHO study group. World Health Organ Tech Rep Ser 1990 ; 797: 1-204.
13. World Health Organization Expert Committee. Arterial hypertension. World Health Organ Tech Rep Ser 1978 ; 628.
14. Shamberger RJ Serum sialic acid in normal and cancer patients. Clin Chem Clin Biochem 1984 ; 22: 64-7.
15. Paterson AD, Rutledge BN, Cleary PA et al. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial 'DCCT'/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 2007 ; 30: 2107-12. (Pubitemid 47219430)
16. American Diabetes Association. Standards of medical care in diabetes. Position Statement. Diabetes Care 2007 ; 30: s4 - s41.
17. UK Prospective Diabetes Study Group 'UKPDS 34'. Effect of intensive blood glucose control with metformin on complications in overweight patients with type2 diabetes. Lancet 1998 ; 7: 854-65.
18. Browning LM, Jebb SA, Mishra GD et al. Elevated sialic acid, but not CRP, predicts features of metabolic syndrome independently of BMI in women. Int J Obes Relat Met Disord 2004 ; 28: 1004-10. (Pubitemid 38998706)
19. Crook MA, Tutt P., Pickup JC Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care 1993 ; 16: 57-60. (Pubitemid 23013825)
20. Wierzbicki AS, Nishtar S., Lumb PJ et al. Metabolic syndrome and risk of coronary heart disease in a Pakistani cohort. Heart 2005 ; 91: 1003-07. (Pubitemid 41060001)
21. Deepa R., Rema M., Mohan V. Lack of association between serum sialic acid levels and retinopathy in type2 diabetic patients. Diab Res Clin Pract 1998 ; 41: 165-69. (Pubitemid 28481335)
22. Nayak SB, Bhaktha G. Relationship between sialic acid and metabolic variables in Indian type2 diabetic patients. Lipids Health Dis 2005 ; 4: 15.
23. Lindberg G., Iso H., Rastam L., Lundblad A., Folsam AR Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA. Int J Epidemiol 1997 ; 26: 58-63. (Pubitemid 27129568)